APA (7th ed.) Citation

Yubero, A., Barquín, A., Estévez, P., Pajares, B., Sánchez, L., Reche, P., . . . Casado, V. (2022). Rucaparib in recurrent ovarian cancer: Real-world experience from the rucaparib early access programme in Spain - A GEICO study. BMC Cancer, 22(1), 1. https://doi.org/10.1186/s12885-022-10191-5

Chicago Style (17th ed.) Citation

Yubero, Alfonso, et al. "Rucaparib in Recurrent Ovarian Cancer: Real-world Experience from the Rucaparib Early Access Programme in Spain - A GEICO Study." BMC Cancer 22, no. 1 (2022): 1. https://doi.org/10.1186/s12885-022-10191-5.

MLA (9th ed.) Citation

Yubero, Alfonso, et al. "Rucaparib in Recurrent Ovarian Cancer: Real-world Experience from the Rucaparib Early Access Programme in Spain - A GEICO Study." BMC Cancer, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12885-022-10191-5.